No Survival Difference Between Re-Resection, Percutaneous RFA in Recurrent HCC No Survival Difference Between Re-Resection, Percutaneous RFA in Recurrent HCC

In patients with early-stage recurrent hepatocellular carcinoma (HCC), long-term survival does not differ between repeat hepatectomy and percutaneous radiofrequency ablation (RFA), a randomized trial in China suggests.Reuters Health Information
Source: Medscape General Surgery Headlines - Category: Surgery Tags: Hematology-Oncology News Source Type: news